324 related articles for article (PubMed ID: 23186214)
1. Invasive pneumococcal disease in Australia 2007 and 2008.
Barry C; Krause VL; Cook HM; Menzies RI
Commun Dis Intell Q Rep; 2012 Jun; 36(2):E151-65. PubMed ID: 23186214
[TBL] [Abstract][Full Text] [Related]
2. Invasive pneumococcal disease in Australia, 2006.
Roche PW; Krause V; Cook H; Barralet J; Coleman D; Sweeny A; Fielding J; Giele C; Gilmour R; Holland R; Kampen R; ; Brown M; Gilbert L; Hogg G; Murphy D;
Commun Dis Intell Q Rep; 2008 Mar; 32(1):18-30. PubMed ID: 18522302
[TBL] [Abstract][Full Text] [Related]
3. Invasive pneumococcal disease in Australia, 2004.
Roche PW; Krause VL; Bartlett M; Coleman D; Cook H; Davis C; Fielding JE; Holland R; Giele C; Gilmour R; Kampen R; Brown M; Gilbert L; Hogg G; Murphy D;
Commun Dis Intell Q Rep; 2006; 30(1):80-92. PubMed ID: 16637236
[TBL] [Abstract][Full Text] [Related]
4. Invasive pneumococcal disease in Australia, 2005.
Roche P; Krause V; Cook H; Bartlett M; Coleman D; Davis C; Fielding J; Giele C; Gilmour R; Holland R; Kampen R;
Commun Dis Intell Q Rep; 2007 Mar; 31(1):86-100. PubMed ID: 17503648
[TBL] [Abstract][Full Text] [Related]
5. Invasive pneumococcal disease in Australia, 2009 and 2010.
Bareja C; Toms C; Lodo K; de Kluyver R;
Commun Dis Intell Q Rep; 2015 Jun; 39(2):E265-79. PubMed ID: 26234260
[TBL] [Abstract][Full Text] [Related]
6. Laboratory surveillance of invasive pneumococcal disease in Australia, 2003 predicting the future impact of the universal childhood conjugate vaccine program.
Watson M; Roche P; Bayley K; Bell JM; Collignon P; Gilbert GL; Hogg G; Keil AD; Krause V; Murphy D; Smith HV; Brown M; Stylianopoulos J; Turnidge J
Commun Dis Intell Q Rep; 2004; 28(4):455-64. PubMed ID: 15745392
[TBL] [Abstract][Full Text] [Related]
7. The changing epidemiology of invasive pneumococcal disease in aboriginal and non-aboriginal western Australians from 1997 through 2007 and emergence of nonvaccine serotypes.
Lehmann D; Willis J; Moore HC; Giele C; Murphy D; Keil AD; Harrison C; Bayley K; Watson M; Richmond P
Clin Infect Dis; 2010 Jun; 50(11):1477-86. PubMed ID: 20420501
[TBL] [Abstract][Full Text] [Related]
8. Laboratory surveillance of invasive pneumococcal disease in Australia in 2001 to 2002--implications for vaccine serotype coverage.
Watson M; Bayley K; Bell JM; Gilbert GL; Hogg G; Keil AD; Krause V; Murphy D; Roche P; Smith HV; Stewart MG; Stylianopoulos J; Turnidge J
Commun Dis Intell Q Rep; 2003; 27(4):478-87. PubMed ID: 15508501
[TBL] [Abstract][Full Text] [Related]
9. Invasive pneumococcal disease in Australia, 2001.
Roche P; Krause V;
Commun Dis Intell Q Rep; 2002; 26(4):505-19. PubMed ID: 12549516
[TBL] [Abstract][Full Text] [Related]
10. Invasive pneumococcal disease in Australia, 2002.
Roche P; Krause V; Andrews R; Carter L; Coleman D; Cook H; Counahan M; Giele C; Gilmore R; Hart S; Pugh R; Hogg G; Murphy D; Watson M;
Commun Dis Intell Q Rep; 2003; 27(4):466-77. PubMed ID: 15508500
[TBL] [Abstract][Full Text] [Related]
11. Pneumococcal disease in South Australia: vaccine success but no time for complacency.
Johnson DR; D'Onise K; Holland RA; Raupach JC; Koehler AP
Vaccine; 2012 Mar; 30(12):2206-11. PubMed ID: 22273663
[TBL] [Abstract][Full Text] [Related]
12. Invasive pneumococcal disease in Australia, 2011 and 2012.
Toms C; de Kluyver R;
Commun Dis Intell Q Rep; 2016 Jun; 40(2):E267-84. PubMed ID: 27522138
[TBL] [Abstract][Full Text] [Related]
13. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2006-2010.
Naidu L; Chiu C; Habig A; Lowbridge C; Jayasinghe S; Wang H; McIntyre P; Menzies R
Commun Dis Intell Q Rep; 2013 Dec; 37 Suppl():S1-95. PubMed ID: 24410428
[TBL] [Abstract][Full Text] [Related]
14. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait.
Mokaddas E; Albert MJ
Vaccine; 2012 Dec; 30 Suppl 6():G37-40. PubMed ID: 23228356
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of impact of 23 valent pneumococcal polysaccharide vaccine following 7 valent pneumococcal conjugate vaccine in Australian Indigenous children.
Jayasinghe S; Chiu C; Menzies R; Lehmann D; Cook H; Giele C; Krause V; McIntyre P
Vaccine; 2015 Nov; 33(48):6666-74. PubMed ID: 26519550
[TBL] [Abstract][Full Text] [Related]
16. Invasive pneumococcal disease in Australia, 2003.
Roche P; Krause V; Bartlett M; Coleman D; Cook H; Counahan M; Davis C; Del Fabbro L; Giele C; Gilmore R; Kampen R; Young M; Hogg G; Murphy D; Watson M
Commun Dis Intell Q Rep; 2004; 28(4):441-54. PubMed ID: 15745391
[TBL] [Abstract][Full Text] [Related]
17. Changing serotypes causing childhood invasive pneumococcal disease: Massachusetts, 2001-2007.
Hsu KK; Shea KM; Stevenson AE; Pelton SI;
Pediatr Infect Dis J; 2010 Apr; 29(4):289-93. PubMed ID: 19935447
[TBL] [Abstract][Full Text] [Related]
18. Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine.
Lacapa R; Bliss SJ; Larzelere-Hinton F; Eagle KJ; McGinty DJ; Parkinson AJ; Santosham M; Craig MJ; O'Brien KL
Clin Infect Dis; 2008 Aug; 47(4):476-84. PubMed ID: 18627249
[TBL] [Abstract][Full Text] [Related]
19. High nasopharyngeal carriage of non-vaccine serotypes in Western Australian aboriginal people following 10 years of pneumococcal conjugate vaccination.
Collins DA; Hoskins A; Bowman J; Jones J; Stemberger NA; Richmond PC; Leach AJ; Lehmann D
PLoS One; 2013; 8(12):e82280. PubMed ID: 24349245
[TBL] [Abstract][Full Text] [Related]
20. Epidemiologic characteristics, serotypes, and antimicrobial susceptibilities of invasive Streptococcus pneumoniae isolates in a nationwide surveillance study in Lebanon.
Hanna-Wakim R; Chehab H; Mahfouz I; Nassar F; Baroud M; Shehab M; Pimentel G; Wasfy M; House B; Araj G; Matar G; Dbaibo G;
Vaccine; 2012 Dec; 30 Suppl 6():G11-7. PubMed ID: 23228352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]